Daniel J. Diekema

Daniel J. Diekema's AcademicInfluence.com Rankings

Daniel J. Diekema

Medical

#1617

World Rank

#1975

Historical Rank

Public Health

#219

World Rank

#228

Historical Rank

medical Degrees

Daniel J. Diekema

Philosophy

#4928

World Rank

#7608

Historical Rank

Logic

#2290

World Rank

#3253

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Daniel J. Diekema's Degrees

Doctorate Medicine University of Iowa
Masters Public Health University of Iowa

Why Is Daniel J. Diekema Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel J. Diekema's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) (3773)
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. (2001) (1432)
Attributable mortality of nosocomial candidemia, revisited. (2003) (1130)
Epidemiology of Invasive Mycoses in North America (2010) (865)
Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus (2004) (708)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion (2010) (666)
International Surveillance of Bloodstream Infections Due toCandida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program (2001) (539)
Methicillin-Resistant Staphylococcus aureus (MRSA) Strain ST398 Is Present in Midwestern U.S. Swine and Swine Workers (2009) (461)
Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases (2005) (439)
Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012 (2012) (422)
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. (2004) (421)
Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study (2002) (395)
Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 (2007) (393)
In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance (2007) (393)
Effect of coinfection with GB virus C on survival among patients with HIV infection. (2001) (360)
Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi (2003) (358)
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. (2012) (342)
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008 (2014) (336)
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 (2019) (333)
Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000 (2002) (331)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing (2007) (328)
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. (2011) (327)
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. (1999) (327)
Epidemiology and Outcome of Nosocomial and Community-Onset Bloodstream Infection (2003) (305)
Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing (2006) (300)
The changing epidemiology of healthcare-associated candidemia over three decades. (2012) (297)
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. (2010) (296)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing (2007) (294)
Adverse outcomes associated with Contact Precautions: a review of the literature. (2009) (291)
Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility (2002) (285)
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. (2004) (282)
Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints (2006) (272)
In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp (2002) (250)
Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints (2008) (250)
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. (2004) (247)
Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. (2014) (238)
Results from the ARTEMIS DISK Global AntifungalSurveillance Study: a 6.5-Year Analysis of Susceptibilitiesof Candida and Other Yeast Species to Fluconazole andVoriconazole by Standardized Disk Diffusion Testing (2005) (234)
Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. (2015) (232)
Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 (2007) (230)
Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene (2011) (224)
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. (2009) (224)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document) (2010) (220)
Antimicrobial resistance trends and outbreak frequency in United States hospitals. (2004) (217)
Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004) (2005) (211)
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program (2019) (210)
Oxazolidinone antibiotics (2001) (208)
Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001 (2003) (206)
Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011 (2013) (204)
Effects of Rapid Detection of Bloodstream Infections on Length of Hospitalization and Hospital Charges (2003) (202)
In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance (2006) (200)
Developing a New, National Approach to Surveillance for Ventilator-Associated Events* (2013) (197)
Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis (2008) (193)
Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. (2002) (193)
Detection and Treatment of Bloodstream Infection: Laboratory Reporting and Antimicrobial Management (2003) (191)
Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002 (2004) (191)
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species (2010) (186)
In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole (2005) (183)
In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from Blood (2003) (175)
Candida guilliermondii, an Opportunistic Fungal Pathogen with Decreased Susceptibility to Fluconazole: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program (2006) (170)
Determining the Clinical Significance of Coagulase-Negative Staphylococci Isolated From Blood Cultures (2005) (164)
In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates (2003) (164)
Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals. (2015) (157)
Minimizing the Workup of Blood Culture Contaminants: Implementation and Evaluation of a Laboratory-Based Algorithm (2002) (147)
Diagnostic Stewardship—Leveraging the Laboratory to Improve Antimicrobial Use (2017) (145)
Multicenter Comparison of the VITEK 2 Antifungal Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Amphotericin B, Flucytosine, and Voriconazole against Candida spp (2007) (144)
Continued Emergence of USA300 Methicillin-Resistant Staphylococcus aureus in the United States: Results from a Nationwide Surveillance Study (2014) (142)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution (2012) (135)
Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States (2014) (134)
Prevalence of the Use of Central Venous Access Devices Within and Outside of the Intensive Care Unit: Results of a Survey Among Hospitals in the Prevention Epicenter Program of the Centers for Disease Control and Prevention (2003) (133)
Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. (2000) (133)
Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007 (2009) (132)
Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods (2009) (132)
A Multicenter Intervention to Prevent Catheter-Associated Bloodstream Infections (2006) (132)
In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model (2007) (131)
Enhanced Identification of Postoperative Infections among Inpatients (2004) (130)
In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species (2008) (125)
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. (2011) (125)
In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model (2008) (125)
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. (2000) (124)
In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods (2009) (121)
Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains (2010) (119)
Moving Personal Protective Equipment Into the Community: Face Shields and Containment of COVID-19. (2020) (118)
Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida (2003) (117)
Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis: a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 (2008) (116)
In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of Candida spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing Methods (2002) (116)
Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens (2009) (115)
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. (2007) (113)
Seasonality of staphylococcal infections. (2012) (111)
Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000. (2002) (110)
Activities of Available and Investigational Antifungal Agents against Rhodotorula Species (2005) (107)
Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program (2019) (106)
Look before you leap: active surveillance for multidrug-resistant organisms. (2007) (103)
Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location (2003) (103)
In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method (2009) (102)
Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature (2009) (99)
Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida spp (2006) (99)
Candida rugosa, an Emerging Fungal Pathogen with Resistance to Azoles: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program (2006) (97)
Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review (2017) (97)
Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs (2012) (94)
Global Surveillance of In Vitro Activity of Micafungin against Candida: a Comparison with Caspofungin by CLSI-Recommended Methods (2006) (94)
An outbreak of Candida parapsilosis prosthetic valve endocarditis. (1997) (94)
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. (2004) (92)
Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates (2004) (92)
Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Institute-Recommended Broth Microdilution Methods (2006) (91)
Lodderomyces elongisporus Masquerading as Candida parapsilosis as a Cause of Bloodstream Infections (2007) (91)
Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program (2005) (87)
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. (2000) (87)
Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles (2010) (86)
Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem (2019) (83)
In Vitro Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans, and Aspergillus Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods (2005) (83)
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. (2010) (82)
An Outbreak of Severe Clostridium difficile–Associated Disease Possibly Related to Inappropriate Antimicrobial Therapy for Community-Acquired Pneumonia (2007) (82)
Multicenter Comparison of the VITEK 2 Yeast Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Fluconazole against Candida spp (2007) (82)
Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. (2010) (81)
Evaluation of Postprescription Review and Feedback as a Method of Promoting Rational Antimicrobial Use: A Multicenter Intervention (2012) (80)
In Vitro Susceptibility Testing of Aspergillus spp.: Comparison of Etest and Reference Microdilution Methods for Determining Voriconazole and Itraconazole MICs (2003) (79)
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. (2008) (78)
Antibacterial properties of the CFTR potentiator ivacaftor. (2014) (76)
Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009 (2011) (76)
Chlorhexidine and Mupirocin Susceptibilities of Methicillin-Resistant Staphylococcus aureus from Colonized Nursing Home Residents (2012) (76)
Cross-Resistance between Fluconazole and Ravuconazole and the Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Ravuconazole among 12,796 Clinical Isolates of Candida spp (2004) (75)
Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014 (2017) (74)
Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods (2011) (74)
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. (2000) (73)
Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates (2013) (71)
Contributions of Aspergillus fumigatus ATP-Binding Cassette Transporter Proteins to Drug Resistance and Virulence (2013) (70)
Rapid Detection of Antimicrobial-Resistant Organism Carriage: an Unmet Clinical Need (2004) (69)
Hospital privacy curtains are frequently and rapidly contaminated with potentially pathogenic bacteria. (2012) (68)
Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values (2011) (67)
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. (2006) (67)
Mycobacterium chimaera Outbreak Associated With Heater-Cooler Devices: Piecing the Puzzle Together (2016) (66)
Evaluation of the Etest and Disk Diffusion Methods for Determining Susceptibilities of 235 Bloodstream Isolates of Candida glabrata to Fluconazole and Voriconazole (2003) (66)
Comparison of the Vitek Gram-Positive Susceptibility 106 Card and the MRSA-Screen Latex Agglutination Test for Determining Oxacillin Resistance in Clinical Bloodstream Isolates of Staphylococcus aureus (2001) (65)
Unusual Fungal and Pseudofungal Infections of Humans (2005) (65)
Effectiveness of Anidulafungin in Eradicating Candida Species in Invasive Candidiasis (2005) (65)
Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Panel for Antifungal Susceptibility Testing of the Echinocandins Anidulafungin, Caspofungin, and Micafungin (2008) (65)
Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values. (2012) (64)
Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method. (2011) (64)
Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida (2011) (63)
Rapid detection of antibiotic-resistant organism carriage for infection prevention. (2013) (62)
Antimicrobial Use Control Measures to Prevent and Control Antimicrobial Resistance in US Hospitals (2006) (61)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution (2010) (61)
Bioaerosol concentrations generated from toilet flushing in a hospital-based patient care setting (2018) (60)
Nosocomial Candidemia: An Ounce of Prevention Is Better Than a Pound of Cure (2004) (59)
Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin (2010) (59)
Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program (2007) (59)
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. (2001) (56)
Public Reporting of Health Care–Associated Surveillance Data: Recommendations From the Healthcare Infection Control Practices Advisory Committee (2013) (56)
Clinical significance of positive cranial bone flap cultures and associated risk of surgical site infection after craniotomies or craniectomies. (2011) (55)
Isavuconazole Pharmacodynamic Target Determination for Candida Species in an In Vivo Murine Disseminated Candidiasis Model (2013) (55)
Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria (2014) (55)
Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United States (2011) (54)
Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. (2008) (51)
Evaluation of Etest Method for Determining Fluconazole and Voriconazole MICs for 279 Clinical Isolates of Candida Species Infrequently Isolated from Blood (2003) (50)
Improving the assessment of vancomycin-resistant enterococci by routine screening. (2007) (50)
Varying Rates of Clostridium Difficile-Associated Diarrhea at Prevention Epicenter Hospitals (2005) (50)
Evaluation of the Etest Method Using Mueller-Hinton Agar with Glucose and Methylene Blue for Determining Amphotericin B MICs for 4,936 Clinical Isolates of Candida Species (2004) (50)
Molecular Epidemiology of Macrolide Resistance in Neonatal Bloodstream Isolates of Group B Streptococci (2003) (50)
Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program (2008) (49)
Comparison of Results of Fluconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program (2004) (49)
Analysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolates. (2007) (48)
Incidence and Outcomes Associated With Clostridium difficile Infections (2020) (48)
Candidemia surveillance in Iowa: emergence of echinocandin resistance. (2014) (47)
Universal precautions training of preclinical students: impact on knowledge, attitudes, and compliance. (1995) (47)
Novel Hospital Curtains with Antimicrobial Properties: A Randomized, Controlled Trial (2012) (47)
Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA (2009) (46)
Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method (2008) (46)
Discontinuing contact precautions for multidrug‐resistant organisms: A systematic literature review and meta‐analysis (2017) (46)
In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs. (2003) (46)
Molecular Phylogenetic Analysis of a Geographically and Temporally Matched Set of Candida albicans Isolates from Humans and Nonmigratory Wildlife in Central Illinois (2008) (45)
Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria (2013) (45)
Developing a New, National Approach to Surveillance for Ventilator-Associated Events: Executive Summary (2013) (44)
Point-Counterpoint: To Screen or Not To Screen for Methicillin-Resistant Staphylococcusaureus (2010) (44)
Developing a new, national approach to surveillance for ventilator-associated events: executive summary. (2013) (43)
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection. (2009) (43)
In Vitro Activities of BMS-207147 against Over 600 Contemporary Clinical Bloodstream Isolates of Candida Species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America (1999) (43)
International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass. (2019) (42)
Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method (2013) (41)
Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. (2014) (41)
Ebola virus disease and the need for new personal protective equipment. (2014) (41)
Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? (2004) (40)
Comparison of the Broth Microdilution Methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for Testing Itraconazole, Posaconazole, and Voriconazole against Aspergillus Isolates (2011) (40)
Identification and Susceptibility Profile of Candida fermentati from a Worldwide Collection of Candida guilliermondii Clinical Isolates (2008) (40)
Preventing MRSA infections: finding it is not enough. (2008) (39)
Prevalence and Genetic Relatedness of Methicillin-Susceptible Staphylococcus aureus Isolates Detected by the Xpert MRSA Nasal Assay (2011) (38)
Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis (2011) (38)
Evaluation of Etest Method for Determining Voriconazole and Amphotericin B MICs for 162 Clinical Isolates of Cryptococcus neoformans (2003) (38)
Optimizing Echinocandin Dosing and Susceptibility Breakpoint Determination via In Vivo Pharmacodynamic Evaluation against Candida glabrata with and without fks Mutations (2012) (38)
Mycobacterium chimaera Infections Associated With Contaminated Heater-Cooler Devices for Cardiac Surgery: Outbreak Management (2017) (38)
Activities of Vancomycin, Ceftaroline, and Mupirocin against Staphylococcus aureus Isolates Collected in a 2011 National Surveillance Study in the United States (2013) (37)
Fluoroquinolone resistance in Streptococcus pyogenes. (2003) (37)
Prevalence, antibiotic resistance and molecular characterisation of Staphylococcus aureus in pigs at agricultural fairs in the USA (2012) (37)
Comparison of the Vitek Gram-Positive Susceptibility 106 Card, the MRSA-Screen Latex Agglutination Test, and mecA Analysis for Detecting Oxacillin Resistance in a Geographically Diverse Collection of Clinical Isolates of Coagulase-Negative Staphylococci (2001) (37)
Contributions of both ATP-Binding Cassette Transporter and Cyp51A Proteins Are Essential for Azole Resistance in Aspergillus fumigatus (2017) (36)
Diagnosing and Reporting of Central Line–Associated Bloodstream Infections (2012) (36)
Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers. (1999) (35)
Screening for Staphylococcus aureus carriage in pregnancy: usefulness of novel sampling and culture strategies. (2009) (35)
Evaluation of the NCCLS M44-P Disk Diffusion Method for Determining Susceptibilities of 276 Clinical Isolates of Cryptococcus neoformans to Fluconazole (2004) (34)
Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. (2013) (34)
Comparison of Activities of Broad-Spectrum β-Lactam Compounds against 1,128 Gram-Positive Cocci Recently Isolated in Cancer Treatment Centers (1999) (33)
Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers. (2014) (33)
Implementation of Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in U.S. Hospitals (2005) (33)
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program. (2009) (31)
Multicenter Comparison of the Vitek 2 Antifungal Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Caspofungin, Micafungin, and Posaconazole against Candida spp (2011) (31)
The yeast connection: is Candida linked to breastfeeding associated pain? (2006) (30)
Lessons Learned From Hospital Ebola Preparation (2015) (29)
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. (2009) (29)
Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA (2016) (29)
Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013 (2016) (29)
Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance Program (2011) (29)
The Epidemiology of Invasive Candidiasis (2012) (28)
Comparing and optimizing ultraviolet germicidal irradiation systems use for patient room terminal disinfection: an exploratory study using radiometry and commercial test cards (2018) (28)
Employee Health and Infection Control (1995) (28)
Evaluation of Disk Diffusion and Etest Compared to Broth Microdilution for Antifungal Susceptibility Testing of Posaconazole against Clinical Isolates of Filamentous Fungi (2007) (27)
Evaluation of Etest and Disk Diffusion Methods Compared with Broth Microdilution Antifungal Susceptibility Testing of Clinical Isolates of Candida spp. against Posaconazole (2007) (27)
Failure of Risk-Adjustment by Test Method for C. difficile Laboratory-Identified Event Reporting (2016) (26)
Risk Factors for Groin Wound Infection After Femoral Artery Catheterization A Case-Control Study (2006) (26)
Stability of Mueller-Hinton Agar Supplemented with Glucose and Methylene Blue for Disk Diffusion Testing of Fluconazole and Voriconazole (2004) (26)
Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods. (2010) (26)
Current Practice in Staphylococcus aureus Screening and Decolonization (2011) (23)
Decline in invasive MRSA infection: where to go from here? (2010) (23)
Genomic Analysis of Cardiac Surgery–Associated Mycobacterium chimaera Infections, United States (2019) (23)
Health Care Resource Utilization Associated with Treatment of Penicillin‐Susceptible and ‐Nonsusceptible Isolates of Streptococcus pneumoniae (2003) (23)
Long-Term Risk for Readmission, Methicillin-Resistant Staphylococcus aureus (MRSA) Infection, and Death among MRSA-Colonized Veterans (2012) (23)
Ebola Fever: Reconciling Planning With Risk in U.S. Hospitals (2014) (22)
Development of a Prediction Rule for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Carriage in a Veterans Affairs Medical Center Population (2008) (22)
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus (2012) (22)
Evaluation of Pneumococcal Serotyping by Multiplex PCR and Quellung Reactions (2013) (21)
Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals. (1999) (21)
Ethical Implications of Active Surveillance Cultures and Contact Precautions for Controlling Multidrug Resistant Organisms in the Hospital Setting (2008) (21)
Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017). (2020) (21)
Methicillin-Resistant Staphylococcus aureus in Pork Production Shower Facilities (2010) (20)
Multicenter Evaluation of the New Vitek 2 Yeast Susceptibility Test Using New CLSI Clinical Breakpoints for Fluconazole (2014) (20)
Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis (2020) (20)
Concordance of nasal and diabetic foot ulcer staphylococcal colonization. (2014) (19)
Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study (2006) (19)
Blood and body fluid exposures during clinical training (1996) (19)
Impact of Infectious Disease Consultation in Patients With Candidemia: A Retrospective Study, Systematic Literature Review, and Meta-analysis (2020) (19)
Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States. (2011) (18)
Epidemiology of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus in a Rural State (2006) (18)
Infection Control Epidemiology and Clinical Microbiology (2011) (18)
Staphylococcus aureus Nasal Colonization and Colonization or Infection at Other Body Sites in Patients on a Burn Trauma Unit (2009) (17)
Importance of Control Group Selection for Evaluating Antimicrobial Use as a Risk Factor for Methicillin-Resistant Staphylococcus Aureus Bacteremia (2005) (17)
Accuracy and Appropriateness of Antimicrobial Susceptibility Test Reporting for Bacteria Isolated from Blood Cultures (2004) (17)
Screening of a Large Global Aspergillus fumigatus Species Complex Collection by Using a Species-Specific Microsphere-Based Luminex Assay (2009) (16)
Quorum Sensing, Virulence, and Antibiotic Resistance of USA100 Methicillin-Resistant Staphylococcus aureus Isolates (2019) (16)
Developing a New, National Approach to Surveillance for Ventilator-Associated Events: Executive Summary (2013) (16)
Emergence of the USA300 Strain of Methicillin-Resistant Staphylococcus aureus in a Burn-Trauma Unit (2008) (16)
A Cluster of Serious Escherichia coli Infections in a Neonatal Intensive-Care Unit (1997) (15)
COVID-19 Serial Testing among Hospitalized Patients in a Midwest Tertiary Medical Center, July–September 2020 (2020) (15)
Developing a new, national approach to surveillance for ventilator-associated events. (2013) (15)
Clinical Evaluation of a Frozen Commercially Prepared Microdilution Panel for Antifungal Susceptibility Testing of Seven Antifungal Agents, Including the New Triazoles Posaconazole, Ravuconazole, and Voriconazole (2002) (15)
Rising Stakes for Health Care-Associated Infection Prevention: Implications for the Clinical Microbiology Laboratory (2017) (15)
CHAPTER 1 – The epidemiology of fungal infections (2009) (15)
Wild-Type MIC Distributions and Epidemiologic Cutoff Values for Fluconazole and Candida: Time for New Clinical Breakpoints? (2010) (14)
Advancing Diagnostic Stewardship for Healthcare Associated Infections, Antibiotic Resistance, and Sepsis. (2021) (14)
Clinical Microbiology and Infection Prevention (2011) (14)
Variation in the Use of Procedures to Monitor Antimicrobial Resistance in U.S. Hospitals (2005) (12)
MYCOBACTERIUM CHIMAERA INFECTIONS AFTER CARDIOVASCULAR SURGERY: LESSONS FROM A GLOBAL OUTBREAK. (2019) (12)
The Epidemiology of Methicillin-Resistant Staphylococcus aureus on a Burn Trauma Unit (2012) (12)
Executive summary: Developing a new, national approach to surveillance for ventilator-associated events. (2013) (12)
Wide Variability in the Use of Antimicrobial Lock Therapy and Prophylaxis among Infectious Diseases Consultants (2010) (12)
Bioaerosols generated from toilet flushing in rooms of patients with Clostridioides difficile infection (2020) (11)
Novel Staphylococcus aureus Secreted Protein Alters Keratinocyte Proliferation and Elicits a Proinflammatory Response In Vitro and In Vivo. (2015) (11)
Motivation for hepatitis B vaccine acceptance among medical and physician assistant students (2007) (11)
Student health policies of U.S. medical schools (1996) (10)
Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans. (2004) (10)
Comparing brief, covert, directly observed hand hygiene compliance monitoring to standard methods: A multicenter cohort study (2019) (10)
Point-Counterpoint: Active Surveillance for Carriers of Toxigenic Clostridium difficile Should Be Performed To Guide Prevention Efforts (2018) (10)
Mycobacterium chimaera Outbreak Response: Experience From Four United States Healthcare Systems (2016) (9)
Development and Validation of Measures to Assess Prevention and Control of AMR in Hospitals (2007) (9)
Negative pressure face shield for flexible laryngoscopy in the COVID‐19 era (2020) (9)
Prevention of Health Care-Associated Infections (2015) (9)
Influenza Vaccination Rates, Feedback, and the Hawthorne Effect (2006) (9)
A Multicenter Intervention to Prevent Catheter-Associated Bloodstream Infections (2006) (9)
Chapter 10 – Infections caused by non-Candida, non-Cryptococcus yeasts (2009) (9)
DiskDiffusion Testing Using Candida sp. Colonies Taken Directlyfrom CHROMagar Candida Medium May Decrease Time Required To ObtainResults (2005) (9)
Descriptive Epidemiology and Case-Control Study of Patients Colonized With Vancomycin-Resistant Enterococcus and Methicillin-Resistant Staphylococcus aureus (2006) (9)
DEVELOPING A NEW, NATIONAL APPROACH (2013) (8)
How Common Is (2006) (8)
Interpreting SARS-CoV-2 Test Results. (2021) (8)
Practical Considerations for Implementation of SARS-CoV-2 Serological Testing in the Clinical Laboratory: Experience at an Academic Medical Center (2021) (8)
Developing a new national approach to surveillance for ventilator-associated events: executive summary. (2013) (8)
Antimicrobial Therapy for Bloodstream Infection Due to Methicillin-Susceptible Staphylococcus aureus in an Era of Increasing Methicillin Resistance: Opportunities for Antimicrobial Stewardship (2012) (8)
Impact of COVID-19 on an infection prevention and control program, Iowa 2020-2021 (2021) (8)
Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020 (2021) (8)
The Clinician and the Microbiology Laboratory (2003) (7)
Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study (2015) (7)
Nonmenstrual toxic shock syndrome due to methicillin-resistant Staphylococcus aureus. (2008) (7)
Multilaboratory Testing of Antifungal Drug Combinations against Candida Species and Aspergillus fumigatus: Utility of 100 Percent Inhibition as the Endpoint (2014) (7)
Correlation between Broth Microdilution and Disk Diffusion Results when Testing Ceftazidime-Avibactam against a Challenge Collection of Enterobacterales Isolates: Results from a Multilaboratory Study (2020) (6)
Candida albicans isolates from APECED patients show decreased susceptibility to miconazole. (2009) (6)
Diagnostic Stewardship for Comprehensive Gastrointestinal Pathogen Panel Tests (2020) (6)
Infective Endocarditis in the 21st Century (2009) (6)
Alcohol-based hand gels and hand hygiene in hospitals (2002) (6)
In Vitro Activity of Ceftaroline against Clinical Isolates of Streptococcus pneumoniae Recovered in 43 U.S. Medical Centers during 2010-2011 (2012) (6)
Diekema Microdilution Methods , 2010 to 2012 and Laboratory Standards Institute Broth Testing of Candida spp . by Use of Clinical Progress in Antifungal Susceptibility (2012) (6)
Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology (2021) (6)
Utility of Antifungal Susceptibility Testing and Clinical Correlations (2012) (6)
DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR DISEASE CONTROL AND PREVENTION Healthcare Infection Control Practices Advisory Committee (2016) (6)
A randomized control trial evaluating efficacy of antimicrobial impregnated hospital privacy curtains in an intensive care setting. (2020) (6)
Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111 (2015) (6)
Long-term follow-up of post-cardiac surgery Mycobacterium chimaera infections: A 5-center case series. (2019) (6)
Short Communication Antibacterial properties of the CFTR potentiator ivacaftor (2014) (5)
A case of recurrent episodes of Candida parapsilosis fungemia (2006) (5)
Impact of 2018 Changes in National Healthcare Safety Network Surveillance for Clostridium difficile Laboratory-Identified Event Reporting (2018) (5)
Survey of high school athletic programs in Iowa regarding infections and infection prevention policies and practices. (2013) (5)
Coronavirus disease 2019 (COVID-19) incidence after exposures in shared patient rooms in a tertiary-care center in Iowa, July 2020–May 2021 (2021) (5)
Improved Diagnosis of Prosthetic-Joint Infections? (2007) (5)
Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins (2011) (4)
Methicillin-resistant Staphylococcus aureus prevention practices in hospitals throughout a rural state. (2014) (4)
MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis (2021) (4)
Prenatal testing for infectious disease. (2003) (4)
A primer on data visualization in infection prevention and antimicrobial stewardship (2020) (4)
Temporal Trends of Candidemia Incidence Rates and Potential Contributions of Infection Control Initiatives over 18 Years within the US Veteran Health Administration System: A Joinpoint Time-Series Analysis. (2021) (4)
Bacterial Contamination of an Automated Pharmacy Robot Used for Intravenous Medication Preparation (2012) (3)
Phaeoacremonium parasiticum phaeohyphomycosis in a patient with systemic lupus erythematosus treated successfully with surgical debridement and voriconazole: A case report and review of the literature (2014) (3)
Successful termination of an outbreak of Mycobacterium chimaera infections associated with contaminated heater-cooler devices (2020) (3)
Experience With Pretravel Testing for SARS-CoV-2 at an Academic Medical Center (2021) (3)
In Vitro Activity of Anidulafungin and Other Agents against Esophageal Candidiasis-Associated Isolates from a Phase 3 Clinical Trial (2010) (3)
A Multi-Site Evaluation of Two New Echinocandins, Anidulafungin (AND), and Micafungin (MF) on a Colorimetric MIC Susceptibility Test Plate Compared with the CLSI M27 Reference Broth Micro Dilution (BMD) Plate for Antifungal Susceptibility Testing (2007) (3)
Use of active surveillance cultures to control vancomycin-resistant Enterococcus. (2003) (3)
Investigation of a Candida guilliermondii Pseudo-outbreak Reveals a Novel Source of Laboratory Contamination (2017) (2)
Research Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration System (2018) (2)
Antifungal Activity Against a Large Global Collection of Rare Candida Species (2008) (2)
Insertion site inflammation was associated with central-line–associated bloodstream infections at a tertiary-care center, 2015–2018 (2020) (2)
Infection prevention strategies for procedures performed outside operating rooms: A conceptual integrated model. (2018) (2)
Nutritional Supplementation and TB Treatment (2008) (2)
Antiretroviral Therapy During Pregnancy: How Safe? (2006) (2)
Contamination of healthcare workers' hands with E. coli and Klebsiella species after routine patient care: a prospective observational study. (2019) (2)
Days of Antibiotic Spectrum Coverage (DASC): A Novel Metric for Inpatient Antibiotic Consumption. (2021) (2)
Effectiveness and Optimal Duration of Adjunctive Rifampin Treatment in the Management of Staphylococcus aureus Prosthetic Joint Infections After Debridement, Antibiotics, and Implant Retention (2022) (2)
LATE BREAKER ABSTRACTS (2014) (2)
US costs and outcomes associated with Clostridium difficile infections: a systematic literature review, meta-analysis, and mathematical model (2015) (2)
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus (2012) (1)
Principles of diagnostic stewardship: A practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force (2023) (1)
Voriconazole Activity Against Aspergillus spp: Eight Years of Global Surveillance (2008) (1)
The long-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines: A systematic literature review and meta-analysis (2022) (1)
Bat Intrusions at a Tertiary Care Center, Iowa 2018–2020 (2021) (1)
Rapid Influenza Diagnosis in Hospitalized Adults (2007) (1)
Molecular epidemiology of large coronavirus disease 2019 (COVID-19) clusters before and after the implementation of routine serial testing at an academic medical center in Iowa, 2020 (2021) (1)
Use of a transnasal flexible laryngoscope tip for laryngeal culturing: A novel in‐office technique (2021) (1)
Hepatitis C Transmission: Sex or Drugs? (2007) (1)
Combination Testing of MGCD290, a Fungal Histone Deacetylase Inhibitor, with Azole Antifungals against a Large Collection of Clinical Fungal Isolates (2008) (1)
Advances in Preventing Surgical-Site Infections (2010) (1)
Clinical Decision Support Systems to Reduce Unnecessary Clostridoides difficile Testing Across Multiple Hospitals. (2022) (1)
Stable Clostridioides difficile Infection Rates After the Discontinuation of Ultraviolet Light for Terminal Disinfection at a Tertiary Care Center, Iowa 2019-2020. (2021) (1)
Detection of Staphylococcus aureus With Heterogeneous Intermediate-level Resistance to Vancomycin (hVISA) in the United States Running Title: Detection of hVISA (2011) (1)
Assessment of room quality of manual cleaning and turnaround times with and without ultraviolet light at an academic medical center (2020) (1)
Risk Factors for Fluconazole-Resistant (2009) (1)
Impact of expanded influenza post-exposure prophylaxis on healthcare worker absenteeism at a tertiary care center during the 2017–2018 season (2018) (1)
Short-Course Nitrofurantoin for Uncomplicated Cystitis in Women (2007) (1)
In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance (2008) (1)
Draft Genome Sequence of USA100 Methicillin-Resistant Staphylococcus aureus Strain 209 (2018) (1)
Clinical impact of changing to an automated blood-culture system at a small community hospital. (1999) (1)
Decline in Invasive MRSA Infection (2017) (1)
Palliative care consultation in patients with Staphylococcus aureus bacteremia (2021) (1)
Colorectal Cancer Screening for HIV-Infected Patients (2006) (1)
Predicting Community-Onset Candidemia in an Academic Medical Center Using Machine Learning (2020) (1)
Healthcare-associated fungal infections: beyond Candida and Aspergillus. (2007) (1)
Coronavirus disease 2019 (COVID-19) among nonphysician healthcare personnel by work location at a tertiary-care center, Iowa, 2020–2021 (2022) (1)
Determining the Risk of Septic Arthritis Following Intra-Articular Injection of Drugs Mixed At A Tertiary Care Center, 2012–2017 (2019) (1)
Should Quinine Be Used for Uncomplicated Malaria (2009) (0)
Diffusion Testing Voriconazole by Standardized Disk Other Yeast Species to Fluconazole and and Candida Analysis of Susceptibilities of Antifungal Surveillance Study: a 6.5-Year Results from the ARTEMIS DISK Global (2014) (0)
Contact precautions for patients with multidrug-resistant pathogens--reply. (2015) (0)
the assessment vancomycin-resistant enterococci by routine screening. (2007) (0)
Faster Diagnosis of MDR-TB (2006) (0)
Clinical Breakpoints for Fluconazole Yeast Susceptibility Test Using New CLSI Multicenter Evaluation of the New Vitek 2 (2014) (0)
Diagnosis and Management of Prosthetic Joint Infection (2013) (0)
PVL and CA-MRSA: The Plot Thickens (2006) (0)
Trends in MRSA Carriage in the U.S. (2008) (0)
Practical Healthcare Epidemiology (2010) (0)
Hospital-Wide Antibiograms: Good Enough? (2006) (0)
Impact of UV-Light Use on the Quality of Manual Cleaning and Room Turnover Times at a Large Tertiary-Care Hospital, 2019 (2020) (0)
Investigation of a Contaminated, Nationally Distributed, Organ Transplant Preservation Solution — United States, 2016–2017 (2017) (0)
Mycobacterium chimaera and Heater-Cooler Units: Update on a Global Outbreak (2017) (0)
Using Viruses to Detect MRSA and MSSA in Blood Cultures (2011) (0)
“Bundling Up” to Reduce Childhood Infections (2009) (0)
Impact of COVID-19 on Volume of Infection Prevention and Control Calls at a Tertiary-Care Center in Iowa, 2018–2020 (2021) (0)
Rhinoviruses: Beyond the Common Cold (2007) (0)
Tuberculosis Exposure and Conversion Rates Can Guide Deimplementation of Annual Tuberculosis Screening (2020) (0)
HIV Drug Resistance Among Infants (2007) (0)
Acute HCV Infection in HIV-Positive Men (2008) (0)
Pandemic Demand for SARS-CoV-2 Testing Led to Critical Supply and Workforce Shortages in U.S. Clinical and Public Health Laboratories (2023) (0)
Bacterial Vaginosis: Do High Recurrence Rates Suggest Sexual Transmission? (2006) (0)
Absence of vaginal methicillin-resistant staphylococcus aureus (MRSA) carriage in the setting of increasing community-associated MRSA rates (2006) (0)
Administrative coding methods impact surgical site infection rates (2020) (0)
Reduction in Abdominal Hysterectomy Surgical Site Infection Rates After the Addition of Anaerobic Antimicrobial Prophylaxis (2020) (0)
Benefits and Drawbacks of Universal Surveillance of Methicillin-Resistant Staphylococcus aureus. Authors' reply (2008) (0)
2124. A Bundled Intervention Was Associated with Decreased Risk of Complex Staphylococcus aureus Surgical Site Infections among Patients Undergoing Clean Operative Procedures (2018) (0)
Bat intrusions at a tertiary care center in Iowa, 2018–2020 (2021) (0)
Faculty Opinions recommendation of Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. (2013) (0)
Keyboard Contamination: A Reservoir for Hospital Pathogens? (2006) (0)
Preventing MRSA Infection in the Age of Evidence (2015) (0)
A 52-Year-Old Man With Uveitis and Altered Mental Status. (2021) (0)
Administrative Coding Methods Impact Surgical Site Infection Rates (2020) (0)
Pneumonia After Healthcare Exposure (2007) (0)
COVID-19 Conversion after Exposure in a Semiprivate Room at a Tertiary Care Center in Iowa, July–December 2020 (2021) (0)
Influential Publications In Health Care Epidemiology and Infection Control (2015) (0)
A Proposal for the Use of Prediction Markets to Forecast Influenza Activity (2006) (0)
Insertion Site Inflammation Is Associated with Central-Line–Associated Bloodstream Infection (2020) (0)
Reviewers for the EJE 2003 (2004) (0)
Diagnosing Bloodstream Infection: How Many Cultures? (2007) (0)
Detection and Control of Carbapenem-Resistant Enterobacteriaceae (2009) (0)
Increased Fluoroquinolone Use for Outpatient UTIs (2006) (0)
Two Controlled Trials Confirm Effectiveness of Daily Chlorhexidine Bathing (2013) (0)
Chlorhexidine Bathing in the ICU (2009) (0)
Infection Prevention Time Required for Construction and Design at a Large Tertiary-Care Hospital, 2019 (2020) (0)
CCR5 inhibitor shows promise. (2007) (0)
Antibiotic Resistance in Community-Associated MRSA (2007) (0)
Effectiveness and acceptability of intranasal povidone-iodine decolonization among fracture fixation surgery patients to reduce Staphylococcus aureus nasal colonization. (2022) (0)
Multilaboratory Testing of Antifungal Drug Combinations against Candida species and Aspergillus 1 (2014) (0)
Suspected COVID-19 Reinfections at a Tertiary Care Center, Iowa, 2020 (2021) (0)
688. Impact of Expanded Influenza Post-exposure Prophylaxis on Healthcare Worker Absenteeism at a Tertiary Care Center During the 2017–2018 Season (2018) (0)
Association between job role and coronavirus disease 2019 (COVID-19) among healthcare personnel, Iowa, 2021 (2022) (0)
Discontinuing Contact Precautions For Multi-Drug Resistant Microorganisms In The Inpatient Setting (2018) (0)
Diekema fumigatus Aspergillus and Candida albicans beyondPathogens : Concern for Resistance Rare and Emerging Opportunistic Fungal (2004) (0)
Staph vs. Staph: A New Way to Attack (2010) (0)
HIV Testing in the U.S.: A Long Way to Go (2007) (0)
Prognostic Value of CRP in Endocarditis (2008) (0)
Chicken à la Fluoroquinolone: A Risky Recipe? (2006) (0)
Bacterial Pneumonia as Pandemic Flu Killer (2008) (0)
Vancomycin Therapy for MRSA Infections (2006) (0)
Predicting Antibiotic Resistance Using HCAP Criteria (2008) (0)
Benefits and drawbacks of universal surveillance of methicillin-resistant Staphylococcus aureus. (2008) (0)
Faculty Opinions recommendation of Diverse sources of C. difficile infection identified on whole-genome sequencing. (2013) (0)
Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study (2015) (0)
Prevalence of HPV Infection in the U.S. (2006) (0)
Flu Vaccine and GBS: Two Studies, No Answer (2006) (0)
Managing Pharyngitis: Guideline, What Guideline? (2006) (0)
494: Screening for staphylococcus aureus carriage in pregnancy: Utility of novel sampling and culture strategies (2008) (0)
Impact of an Enhanced Prevention Bundle on Central-Line–Associated Bloodstream Infection Incidence in Adult Oncology Units (2020) (0)
Overview of Molecular Diagnostics in Multiple-Drug-Resistant Organism Prevention: Focus on Multiple-Drug-Resistant Gram-Negative Bacterial Organisms (2016) (0)
Persistent Staphylococcus aureus Bacteremia (2007) (0)
Nongonococcal Urethritis — From a Virus? (2006) (0)
Lower Susceptibility Breakpoints for the Enterobacteriaceae (2011) (0)
Reply to Burden et al (2014) (0)
Reconsidering the routine use of contact precautions in preventing the transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings. (2023) (0)
Isavuconazole Pharmacodynamic Target Determination for Candida species in an In vivo 1 (2013) (0)
Human Bocavirus: More Evidence for Pathogenic Potential (2006) (0)
1621US Costs and Outcomes Associated with Clostridium difficile Infections: a Systematic Literature Review, Meta-analysis, and Mathematical Model (2014) (0)
LB-9A Multicenter Intervention to Reduce Surgical Site Infections among Patients Undergoing Cardiac Operations and Total Joint Arthroplasty (STOP SSI Study) (2014) (0)
Do PPIs Increase Risk for CAP (2007) (0)
Tracking Resistance In Streptococcus Pneumoniae (TRISP) (2012) (0)
The clinical significance of coagulase-negative staphylococci-positive blood cultures (2004) (0)
Pregnancy and HIV Disease Progression (2007) (0)
2009 H1N1 Vaccine: Will One Dose Be Enough? (2009) (0)
297Trends in Staphylococcus aureus (SA) Isolation in 28 US Hospitals, 2009-2013 (2014) (0)
Reduction in abdominal hysterectomy surgical site infection rates after the addition of anaerobic antimicrobial prophylaxis (2020) (0)
Occupational HIV Exposure During Primary Infection (2007) (0)
What's New in Fungal Infections? (2023) (0)
Molecular Epidemiology of Large COVID-19 Clusters at an Academic Medical Center, March–October 2020 (2021) (0)
The Importance of Training in Hand Hygiene (2007) (0)
and Interpretive Criteria of Candida by Using CLSI Methods and Caspofungin among 4 , 290 Clinical Isolates To Predict Susceptibility and Resistance to Use of Anidulafungin as a Surrogate Marker (2014) (0)
Bone flap cultures Response (2011) (0)
Introductory Remarks and Awards (2014) (0)
Is Whole-Genome Sequencing the Future of Clinical Microbiology? (2012) (0)
Structured Treatment Interruptions: The Jury Is Still Out (2006) (0)
Early Treatment of Bell Palsy (2007) (0)
Recognizing Influenza in Hospitalized Patients (2006) (0)
Infective Endocarditis in Older Patients (2008) (0)
Pneumococcal Resistance in the Post–Conjugate Vaccine Era (2007) (0)
Procalcitonin to Guide Antibiotic Use in Primary Care (2008) (0)
More Benefits of Chlorhexidine Bathing (2007) (0)
Performance Measures and Pneumonia Diagnoses: Not So Fast! (2008) (0)
Overuse of Empirical Antibiotics for Acute Diarrhea (2008) (0)
Could Early and Continuous HIV Therapy Achieve Eradication (2007) (0)
Error in Discussion. (2021) (0)
Bed-Bath, and Beyond? (2006) (0)
Occupational tuberculosis exposures and conversion rates can guide deimplementation of annual tuberculosis skin test screening (2020) (0)
Influenza Vaccination for School-Age Children (2006) (0)
Comparing and optimizing ultraviolet germicidal irradiation systems use for patient room terminal disinfection: an exploratory study using radiometry and commercial test cards (2018) (0)
Sleep and the Common Cold (2009) (0)
Safety and Immunogenicity of a Live Attenuated WNV Vaccine (2006) (0)
Are MRSA Infections Really More Expensive (2009) (0)
Achieving Immunity in Hepatitis B Vaccine Nonresponders (2008) (0)
1031. Nationwide Temporal Trends of Candidemia Incidence Over 18 Years Within the Veteran Health Administration System (2018) (0)
Public Housing and Public Health: CA-MRSA in Chicago (2007) (0)
Value of the leukocyte count in predicting mortality of patients with community-acquired bacteremia (2004) (0)
Blood culture practices in patients with a central line at an academic medical center—Iowa, 2020 (2022) (0)
TMP-SMX Prophylaxis During Pregnancy: Good for Baby, Too? (2006) (0)
Diagnostic Stewardship to Prevent Diagnostic Error. (2023) (0)
When to Initiate ART (2008) (0)
Improving Environmental Disinfection through Objective Assessments at a Large Teaching Hospital (2019) (0)
MRSA: It’s All in the Family (2006) (0)
Infection and CCR5: A Lot to Learn (2008) (0)
Reducing Length of Stay for CAP Patients (2007) (0)
Improving Antimicrobial Management with Computerized Decision Support (2006) (0)
The Survival Benefit of HIV Treatment in the U.S. (2006) (0)
HIV Transmission During Early Infection (2007) (0)
S 2 : 3 A STudy of oRAl CAndidiASiS in A PoRTuguESE dEnTAl CliniC duRing A onE yEAR PERiod (2008) (0)
Coronavirus Disease 2019 (COVID-19) Admission Screening at a Tertiary-Care Center, Iowa 2020 (2021) (0)
No Need to Treat Asymptomatic Bacteriuria in Women with Diabetes (2006) (0)
Risk factors for stroke in nonrheumatic atrial fibrillation. (1992) (0)
Bioaerosol concentrations generated from toilet flushing in a hospital-based patient care setting (2018) (0)
Ertapenem Prophylaxis in Colorectal Surgery (2006) (0)
Screening of a large , global Aspergillus fumigatus species complex collection using a 1 species specific microsphere based Luminex assay 2 3 4 (2009) (0)
Multidrug-Resistant HIV: A Tale of Two Transmission Events (2007) (0)
Skin and Soft-Tissue Infections on the Rise (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Daniel J. Diekema?

Daniel J. Diekema is affiliated with the following schools:

University of Iowa

Daniel J. Diekema's Academic­Influence.com Rankings

Daniel J. Diekema's Degrees

Why Is Daniel J. Diekema Influential?

Daniel J. Diekema's Published Works

Published Works

What Schools Are Affiliated With Daniel J. Diekema?

Daniel J. Diekema's AcademicInfluence.com Rankings